LCGC president, CSO and founder Melvin Reichman will begin a new global health and development research project, titled "A Totally New Approach to Discover Malaria Combination Drugs.”
Reichman said that the Grand Challenges Explorations Award offers the project team an opportunity to apply LCGC’s screening technologies to discover novel, combination-drug leads against drug-resistant malaria.
The research project is one of over 80 Grand Challenges Explorations Round 9 grants from the Bill & Melinda Gates Foundation.
Bill & Melinda Gates Foundation global health discovery and translational sciences director Chris Wilson said, "We continue to be impressed by the novelty and innovative spirit of Grand Challenges Explorations projects and are enthusiastic about this exciting research."
The LCGC will develop and validate a new, drug-screening paradigm to detect drug synergy against Plasmodium falciparum using antimalarials and has named the technology as ‘ultra-High Throughput Screening for Synergy’.